Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)

Kate Lathrop, MD

Associate Professor, Division of Hematology and Oncology, UT Health San Antonio, Breast Medical Oncology, Mays Cancer Center at UT Health San Antonio, Assistant Dean of Undergraduate Research, Long School of Medicine, UT Health San Antonio, Program Director, Medical Oncology and Hematology Fellowship Program, UT Health San Antonio, Program Director, San Antonio Breast Cancer Symposium (SABCS)

Jennifer M. Matro, MD

Associate Professor of Medicine, Co-Leader, Breast Disease Team, Division of Hematology/Oncology, UC San Diego Comprehensive Breast Health Team

Marcela Mazo Canola, MD

Assistant Professor of Medicine, Division of Hematology – Oncology, Breast Medical Oncology, UT Health San Antonio Mays Cancer Center

Cassie Spector, MSW

Breast and Gynecological Cancers Program Coordinator, CancerCare